Indications and Visual Outcomes of Intravitreal Anti Vascular Endothelial Growth Factor Agents for Retinal Diseases: Vitreo-Retina

O.M Uhumwangho

Authors

O.M Uhumwangho Department of Ophthalmology, University of Benin/ University of Benin Teaching Hospital, P.M.B. 1111, Benin City, Nigeria.

Abstract

Background: Vascular endothelial growth factors (VEGF) play a pivotal role in the occurrence of retinal neovascularization, choroidal neovascularization and retinal vascular permeability. The use of anti VEGF has revolutionalized the treatment of these diseases with reports of efficacy, reversal of visual loss and even regaining of lost vision[1] . The aim was to determine the indications and treatment outcomes for use of intravitreal antiVEGF agents in retinal diseases among patients in a tertiary hospital in Nigeria.

Methods: The case folders of patients who had intravitreal injections of antiVEGF from January 2012 to December 2014 were analyzed. Data retrieved included age, sex, indication, type of intravitreal anti VEGF used, number of injections, visual acuity, treatment outcomes, complications and follow up duration

Views | Downloads: 19 / 16

References

Wong TY, McIntosh R. Hypertensive retinopathy signs as risk indicators of cardiovascular morbidity and mortality. Br Med Bull. 2005;73- 74(1):57–70

Akinkugbe OO. The rarity of hypertensive retinopathy in the African. Am J Med. 1968;45(3):401–404.

Ladipo GO. Hypertensive retinopathy in Nigerians. A prospective clinical study of 350 cases. Trop Geogr Med. 1981;33(4):311–316.

Busari OA, Opadijo OG, Omotoso AB. Microalbuminuria and hypertensive retinopathy among newly diagnosed nondiabetic hypertensive adult Nigerians. Niger J Clin Pract. 2011;14(4):436–439.

Omolase CO, Adekanle O, Omolase BO. Hypertensive retinopathy in a Nigerian Community. Sudan Med J. 2010;46(2):79– 84.

The Eye Disease Case-Control Study Group. Risk factors for central retinal vein occlusion. Arch Ophthalmol. 1996;114(5): 545–554.

Hayreh SS, Servais GE, Virdi PS. Fundus lesions in malignant hypertension: V. Hypertensive optic neuropathy. Ophthalmology.1986; 93(1): 74–87.

Holdeman N, Le H. Retinal arterial macroaneurysm. Clin Sur Ophthalmol, 2010 ;28: 238-242

Wong TY, Klein R, Nieto FJ, Klein BE, Sharrett AR, et al. Retinal microvascular abnormalities and ten-year cardiovascular mortality. A opulation-based casecontrol study. Ophthalmology. 2003;110(5):933–940